PT Jayamas Medica Industri Tbk (IDX:OMED)
Indonesia
· Delayed Price · Currency is IDR 157.00
-4.00 (-2.48%)
Mar 27, 2025, 4:02 PM WIB
IDX:OMED Cash Flow Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | 321,673 | 259,360 | 285,782 | 562,692 | 685,510 | Upgrade
|
| Depreciation & Amortization | - | 56,526 | 41,214 | 34,973 | 16,892 | Upgrade
|
| Other Amortization | - | 427.87 | 431.79 | 659.37 | 1,216 | Upgrade
|
| Other Operating Activities | 29,894 | -181,959 | -234,810 | -93,216 | -424,884 | Upgrade
|
| Operating Cash Flow | 351,568 | 134,354 | 92,617 | 505,108 | 278,735 | Upgrade
|
| Operating Cash Flow Growth | 161.67% | 45.06% | -81.66% | 81.22% | 59.53% | Upgrade
|
| Capital Expenditures | -102,323 | -156,385 | -75,068 | -82,722 | -49,963 | Upgrade
|
| Sale of Property, Plant & Equipment | 10.87 | 409.94 | 0.35 | 38.36 | 2,608 | Upgrade
|
| Sale (Purchase) of Intangibles | -19.39 | -56.12 | -302.25 | -61.94 | -2,482 | Upgrade
|
| Investment in Securities | -61,819 | 420,440 | -419,477 | -104,310 | -5 | Upgrade
|
| Other Investing Activities | - | 185.15 | -251.91 | - | - | Upgrade
|
| Investing Cash Flow | -164,151 | 264,594 | -495,100 | -187,056 | -49,842 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 159,200 | Upgrade
|
| Long-Term Debt Repaid | -17,265 | -25,307 | -36,342 | -17,972 | -2,875 | Upgrade
|
| Net Debt Issued (Repaid) | -17,265 | -25,307 | -36,342 | -17,972 | 156,325 | Upgrade
|
| Issuance of Common Stock | - | - | 780,579 | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -5,500 | Upgrade
|
| Common Dividends Paid | -77,929 | -85,777 | -250,000 | -255,000 | - | Upgrade
|
| Other Financing Activities | - | 505 | -750 | -10,000 | - | Upgrade
|
| Financing Cash Flow | -95,195 | -110,578 | 493,486 | -282,972 | 150,825 | Upgrade
|
| Foreign Exchange Rate Adjustments | 11,911 | 1,654 | 6,704 | 731.57 | 1,097 | Upgrade
|
| Net Cash Flow | 104,133 | 290,023 | 97,708 | 35,812 | 380,815 | Upgrade
|
| Free Cash Flow | 249,245 | -22,031 | 17,549 | 422,386 | 228,771 | Upgrade
|
| Free Cash Flow Growth | - | - | -95.84% | 84.63% | 42.78% | Upgrade
|
| Free Cash Flow Margin | 13.22% | -1.27% | 1.01% | 18.97% | 11.47% | Upgrade
|
| Free Cash Flow Per Share | - | -0.81 | 0.65 | 15.61 | 8.33 | Upgrade
|
| Cash Interest Paid | - | 16,957 | 16,952 | 17,138 | 8,550 | Upgrade
|
| Cash Income Tax Paid | - | 76,907 | 193,043 | 142,710 | 32,617 | Upgrade
|
| Levered Free Cash Flow | 25,330 | -91,618 | 8,156 | 311,711 | 358,952 | Upgrade
|
| Unlevered Free Cash Flow | 37,973 | -79,380 | 21,159 | 325,362 | 364,582 | Upgrade
|
| Change in Net Working Capital | 82,964 | 167,939 | 177,768 | 85,509 | 132,011 | Upgrade
|
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.